热疗可以缓解抑郁症吗? 对生理适应和临床证据的审查
Øyvind A Høydal1, Runa R G Notøy2, Kjetil L Høydal3
1Department of Natural Sciences, Volda University College, Norway.
Brain research
|December 29, 2025
概括
热疗,就像运动一样,可以通过诱导生理变化来为情绪障碍提供好处. 这篇评论探讨了暴露于热和寒冷作为抑郁症和焦虑症的潜在治疗方法.
科学领域:
- 精神病学和行为科学 精神病学和行为科学
- 生理学 生理学 生理学
背景情况:
- 抑郁症和焦虑症等主要情绪障碍越来越普遍.
- 包括运动和热疗在内的生活方式干预正在引起人们对心理健康的关注.
- 虽然运动的好处是众所周知的,但热疗在情绪障碍中的作用不太清楚.
研究的目的:
- 审查与抑郁相关的被动热和冷暴露的生理适应.
- 检查热疗对抑郁障碍的影响的临床证据.
- 讨论未来的热疗治疗情绪障碍治疗的研究方向.
主要方法:
- 对热/冷暴露的生理反应的文献综述.
- 对治疗抑郁症热疗法的临床试验进行系统审查.
- 对热疗在情绪障碍病原发生的潜力的分析.
主要成果:
- 被动热和冷暴露可以触发生理反应,可能抵消抑郁症的病理生理学.
- 有证据表明,热疗可能补充或作为情绪障碍运动的替代品.
- 需要进一步的研究,以充分阐明热疗的疗效和机制.
结论:
- 热疗是一种有希望的,未经研究的治疗情绪障碍的途径.
- 它提供了潜在的替代或辅助疗法,特别是对于无法炼的人来说.
- 未来的研究应该专注于优化热疗方案,了解其神经生物学影响.
相关概念视频
01:30Electroconvulsive Therapy
780
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
780
01:23Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765
01:28Drug Therapy
229
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
229
01:29Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
01:18Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
01:25Interpersonal Psychotherapy
280
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
280